General
Preferred name
N-(p-amylcinnamoyl) Anthranilic Acid
Synonyms
ACA ()
ACAA ()
P&D ID
PD018814
CAS
110683-10-8
99196-74-4
Tags
available
drug candidate
Drug indication
Discovery agent
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Compound Sets
11
Cayman Chemical Bioactives
14531
Concise Guide to Pharmacology 2017/18
2443
Concise Guide to Pharmacology 2019/20
2443
Concise Guide to Pharmacology 2021/22
2443
Concise Guide to Pharmacology 2023/24
2443
Drug Repurposing Hub
DrugMAP
DMACYPW
Guide to Pharmacology
2443
MedChem Express Bioactive Compound Library
HY-118628
Novartis Chemogenetic Library (NIBR MoA Box)
TargetMol Bioactive Compound Library
T5454
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
337.17
Hydrogen Bond Acceptors
2
Hydrogen Bond Donors
2
Rotatable Bonds
8
Ring Count
2
Aromatic Ring Count
2
cLogP
4.77
TPSA
66.4
Fraction CSP3
0.24
Chiral centers
0.0
Largest ring
6.0
QED
0.54
QED
0.54
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Metabolism
Membrane Transporter/Ion Channel
Metabolic Enzyme/Protease
Neuronal Signaling
Target
PLA2
Phospholipase
TRP Channel
MOA
phospholipase
TRPM8 (TRP-p8| CMR1) Antagonists
TRPM2 Antagonists
TRPC6 Inhibitors
Phospholipase A2 (PLA2) Inhibitors
Phospholipase inhibitor
Member status
member
Source data